Related Experiment Videos
Activated ras genes in human seminoma: evidence for tumor heterogeneity
M P Mulder1, W Keijzer, A Verkerk
1Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands.
Abstract:
The incidence of mutations in cellular ras genes was determined in human seminoma, a germ cell tumor of the testis, with the aid of specific oligonucleotide probe hybridization. To eliminate the large number of nonneoplastic cells present in seminomas, aneuploid tumor cell nuclei were isolated from the tumor tissue by flow sorting. Mutations were detected in 40% of the seminomas at codons 12 or 61 of either the Ki-ras or the N-ras gene. No correlation was found with histopathological or clinical features. In some seminomas the mutant gene was present in only a fraction of the tumor cell population, suggesting tumor heterogeneity for ras gene mutations. Yet, flow cytometric measurement of nuclear DNA contents and histological examination of tumor tissue did not reveal two different tumor cell populations. We conclude from these observations that ras mutation is probably not the initial genetic event in the development of seminoma.
Insights
RAS gene mutations were found in 40% of human seminomas, a type of testicular cancer. These mutations may not be the initial event in seminoma development, suggesting complex genetic pathways.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Seminoma is a germ cell tumor of the testis.
- RAS genes are frequently mutated in human cancers.
- Understanding genetic alterations in seminoma is crucial for comprehending its pathogenesis.
Purpose of the Study:
- To determine the incidence of mutations in cellular RAS genes (Ki-ras, N-ras) in human seminoma.
- To investigate the potential correlation between RAS gene mutations and clinicopathological features of seminoma.
- To explore the role of RAS mutations in the early stages of seminoma development.
Main Methods:
- Isolation of aneuploid tumor cell nuclei from seminoma tissue using flow sorting to exclude nonneoplastic cells.
- Detection of mutations at codons 12 or 61 of Ki-ras and N-ras genes using specific oligonucleotide probe hybridization.
- Flow cytometric analysis of nuclear DNA content and histological examination of tumor tissue.
Main Results:
- Mutations in Ki-ras or N-ras genes were detected in 40% of the analyzed seminomas.
- Mutations were identified at codons 12 or 61.
- No significant correlation was observed between RAS gene mutations and histopathological or clinical characteristics.
- Evidence of tumor heterogeneity for RAS gene mutations was found in some cases, with mutant genes present in only a fraction of the tumor cell population.
Conclusions:
- RAS gene mutations are common in human seminoma but may not represent the initial genetic event in tumorigenesis.
- The presence of RAS mutations in a subset of tumor cells suggests potential tumor heterogeneity.
- Further research is needed to elucidate the precise role and timing of RAS mutations in seminoma development.